Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty. - Wikidata - awgldk - TriplyDB

Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.

Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.

http://www.wikidata.org/entity/Q37297626

about

Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.Possible Function of Molecular Chaperones in Diseases Caused by Propagating Amyloid Aggregates.

P2860

Q38659874-8220FC45-592D-4854-BB80-9BBE899E3BF4 Q38755364-BAA03369-C71E-4764-BDA8-1F5CBC2483A6

P2860

Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.

http://www.wikidata.org/entity/Q37297626

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Potential fluid biomarkers for ...... creening of cognitive frailty.

@en

Potential fluid biomarkers for ...... creening of cognitive frailty.

@nl

type

label

Potential fluid biomarkers for ...... creening of cognitive frailty.

@en

Potential fluid biomarkers for ...... creening of cognitive frailty.

@nl

prefLabel

Potential fluid biomarkers for ...... creening of cognitive frailty.

@en

Potential fluid biomarkers for ...... creening of cognitive frailty.

@nl

P1433

Q37297626-5E6A6A57-C92A-4596-B9DE-1B48E81496F6

P1476

Q37297626-FE5874D2-48B8-4010-9959-B3B85115D62C

P2093

Q37297626-007CA8CD-2547-4529-87D7-DEBE1C3A4E7C

Q37297626-6BD3F136-D74F-48FB-BE62-2DB2A5AA50C7

Q37297626-D299F48B-64A2-497C-BF59-7CFDDBBF5EBD

P275

Q37297626-A537BDDF-96CF-429E-BD96-BEBC29FB5D3C

P2860

Q37297626-003D9FFE-E125-4EE9-A3B1-3B5FEAE7C18F

Q37297626-02050268-FA53-43C5-9CBC-F2A0B926DA69

Q37297626-02A2E0C8-5DAA-492F-B3D1-14AA548E5877

Q37297626-03662E0B-C0EE-43BE-B6FA-2C7235964A0E

Q37297626-04C4919E-5979-4639-AF2A-41C8882612DF

Q37297626-05F996EA-C3F4-4196-BF97-9B89BA7B4274

Q37297626-061BF542-1447-46E8-9224-50A022639A9D

Q37297626-08FB2ADD-FF69-4D4E-8A08-904E0FECF0B3

Q37297626-0B788563-DB8B-4FF2-9678-B19DEF9D23FC

Q37297626-0BBAAD28-F4F0-4D84-8395-0A0C8C9BDF63

P304

Q37297626-C0685D74-FBA6-4E65-ABF5-FAAC0CEE5430

P31

Q37297626-7C1EAE92-116B-49BC-B42D-209A2E26B84B

Q37297626-80181FAE-8DD6-496A-B8D2-7D176224C9AD

P356

Q37297626-C7BE38C3-F2FF-4C1B-A71A-52B5B90905ED

P433

Q37297626-93838732-62D1-4845-9134-162F733DC36E

P478

Q37297626-6DF6CA00-A282-478C-9639-DC6E6F394F14

P50

Q37297626-9E29179A-A8D0-4A34-89F1-00FD091F4A54

Q37297626-D6FA0D04-4190-47DD-BF1F-84BA4661E6EE

P5008

Q37297626-D9D2EE7E-3C70-4C24-9652-6587723F5BE7

P577

Q37297626-2031DB50-04CE-4E44-9521-564111E1B705

Q37297626-D8FA31FC-9BF1-4AC3-9159-107647C6DDC2

P698

Q37297626-99300A66-9932-4B50-A207-E6692141E52A

P921

Q37297626-70954C8F-64F8-41F2-BEC1-A7EEB8365E39

Q37297626-752073D2-AA6A-4424-8C38-5D0D02D53BE0

Q37297626-89C7EE04-70FF-407C-8655-9669C10A9495

Q37297626-CDD5AA46-B29A-47AB-A20E-3C926FED103A

P932

Q37297626-0D6D905A-952C-4126-991F-4B254D2A7FE8

P356

P1433

Molecular Medicine Reports

P1476

Potential fluid biomarkers for ...... creening of cognitive frailty.

@en

P2093

Antonio Greco

http://www.w3.org/2001/XMLSchema#string

Qingwei Ruan

http://www.w3.org/2001/XMLSchema#string

Zhuowei Yu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Genetic markers in biological fluids for aging-related major neurocognitive disorder

Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48

Evidence for a membrane defect in Alzheimer disease brain

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative

Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

P304

3184-3198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2016.5618

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Grazia D'Onofrio

Daniele Sancarlo

P5008

P577

2016-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27511317

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cognitive dysfunction

P932

5042792

http://www.w3.org/2001/XMLSchema#string